aspartic acid has been researched along with Experimental Mammary Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Tang, W; Wang, L; Xie, J; Zhao, Q; Zhen, Z | 1 |
| Casper, ES; Martin, DS; Sawyer, RC; Spiegelman, S; Stolfi, RL; Young, CW | 1 |
| Greer, S; Marion, HS; Schwade, J | 1 |
| Colofiore, JR; Martin, DS; Nord, LD; Sternberg, S; Stolfi, RL | 1 |
| Colofiore, JR; Martin, DS; Nord, LD; Stolfi, RL | 2 |
| Ballon, D; Koutcher, JA; Mahmood, U; Martin, DS; Matei, C; Street, JC | 1 |
| Alfieri, AA; Ballon, D; Koutcher, JA; Martin, DS; Matei, C; Stolfi, RL; Tsai, JC | 1 |
| Alfieri, AA; Colofiore, JR; Koutcher, JA; Martin, DS; Netto, G; Nord, LD; Reuter, V; Sternberg, SS; Stolfi, RL | 1 |
| Colofiore, JR; Koutcher, JA; Martin, DS; Nord, LD; Stolfi, RL | 1 |
| Martin, DS; Sawyer, RC; Stolfi, RL | 1 |
| Martin, DS | 1 |
| Akazawa, S; Ayusawa, D; Kumai, R; Seno, T; Shimizu, K; Yoshida, S | 1 |
| de Goeij, CC; Evers, SG; Sluyser, M | 1 |
| Kadohama, N; Turkington, RW | 1 |
| Grossowicz, N; Lichtenstein, N; Schlesinger, M | 1 |
16 other study(ies) available for aspartic acid and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Improving detection specificity of iron oxide nanoparticles (IONPs) using the SWIFT sequence with long T(2) suppression.
Topics: Animals; Arginine; Aspartic Acid; Cell Line, Tumor; Contrast Media; Fourier Analysis; Glycine; Heterografts; Immunohistochemistry; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phantoms, Imaging; Sensitivity and Specificity | 2014 |
Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance.
Topics: Animals; Aspartic Acid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Phosphonoacetic Acid; RNA | 1983 |
Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation.
Topics: Adenocarcinoma; Animals; Aspartic Acid; Body Weight; Deoxycytidine; Idoxuridine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tetrahydrouridine | 1995 |
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed.
Topics: 6-Aminonicotinamide; Animals; Apoptosis; Aspartic Acid; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Energy Metabolism; Mammary Neoplasms, Experimental; Methylthioinosine; Phosphonoacetic Acid | 1994 |
Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
Topics: 6-Aminonicotinamide; Adenosine Kinase; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid | 1996 |
In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Magnetic Resonance Spectroscopy; Male; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred C3H; Pentose Phosphate Pathway; Phosphonoacetic Acid; Phosphorus; Teratogens | 1996 |
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Paclitaxel; Phosphonoacetic Acid; Remission Induction | 1996 |
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Disease Progression; Doxorubicin; Drug Synergism; Evaluation Studies as Topic; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Phosphorus Isotopes; Radiation-Sensitizing Agents | 1997 |
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion.
Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid; Time Factors | 1997 |
Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Orotic Acid; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate | 1992 |
Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Cycle; Female; Fluorouracil; Histidinol; Imidazoles; Lethal Dose 50; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Phosphonoacetic Acid | 1987 |
Cancer chemotherapy: past is prologue.
Topics: 6-Aminonicotinamide; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Male; Mammary Neoplasms, Experimental; Methotrexate; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid | 1985 |
[Biochemical modulation of 5-FU by thymidine and N-phosphoacetyl-L-aspartate: the relation between 5-FU incorporation into RNA and its cytocidal effect].
Topics: Animals; Aspartic Acid; Cell Division; Cell Survival; Cells, Cultured; DNA, Neoplasm; Drug Synergism; Female; Fluorouracil; Mammary Neoplasms, Experimental; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; RNA, Neoplasm; Thymidine; Tumor Stem Cell Assay | 1986 |
Chemotherapy and hormonal therapy of mouse mammary tumors.
Topics: Animals; Aspartic Acid; Body Weight; Cholesterol; Cisplatin; Delayed-Action Preparations; Doxorubicin; Female; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Organophosphorus Compounds; Ovariectomy; Phosphonoacetic Acid; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Altered populations of acidic chromatin proteins in breast cancer cells.
Topics: Adenocarcinoma; Amino Acids; Animals; Aspartic Acid; Chromatin; Electrophoresis, Polyacrylamide Gel; Female; Hydrogen-Ion Concentration; Leucine; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasm Proteins; Organ Culture Techniques; Phosphorus; Pregnancy; Rats; Sodium Dodecyl Sulfate; Tritium | 1973 |
Inhibition of murine tumors by carbobenzoxy derivatives of amino acids.
Topics: Amino Acids; Animals; Antineoplastic Agents; Asparagine; Aspartic Acid; Benzyl Compounds; Carcinoma, Ehrlich Tumor; Cysteine; Formates; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Phenylalanine | 1971 |